Open Access
Open access

Economic Botany

Springer Nature
Springer Nature
ISSN: 00130001, 18749364

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q2
WOS
Q2
Impact factor
1.7
SJR
0.395
CiteScore
4.1
Categories
Horticulture
Plant Science
Areas
Agricultural and Biological Sciences
Years of issue
1947-2025
journal names
Economic Botany
ECON BOT
Publications
4 150
Citations
67 885
h-index
103
Top-3 citing journals
Top-3 organizations
Top-3 countries
USA (1738 publications)
United Kingdom (312 publications)
Mexico (141 publications)

Most cited in 5 years

Found 
from chars
Publications found: 900
An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer’s disease: the role of apolipoprotein E
Lozupone M., Dibello V., Daniele A., Panza F.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder
Carnero Contentti E., Correale J.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Emerging treatments for sarcoma: from 2024 onward
Gómez-Puerto D., Cicala C.M., Valverde C., Serrano C.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Emerging biological treatments for asthma
Pastore D., Lupia C., D’Amato M., Bruni A., Garofalo E., Longhini F., Gallelli L., Vatrella A., Pelaia G., Pelaia C.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Mitapivat: a step forward across different hemolytic diseases
Hodroj M.H., Klim J., Charbel N., Taher A.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
FcRn inhibitors in the context of myasthenia gravis
Menon D., Bhandari V.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Muscarinic M1 and M4 agents as treatments for schizophrenia: what do they do and who do they do it for?
Harvey P.D.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Systemic therapy for Child-Pugh B patients with hepatocellular carcinoma
Mok K., Chen O., Yau J., Chan L.L., Chan S.L.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Seltorexant for major depressive disorder
Valentino K., Teopiz K.M., Wong S., Zhang M.C., Le G.H., Choi H., Ballum H., Dri C., Cheung W., McIntyre R.S.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2025 citations by CoLab: 0
Exploring emerging JAK inhibitors in the treatment of aicardi-goutières syndrome
Politano D., Tonduti D., Battini R., Fazzi E., Orcesi S.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2024 citations by CoLab: 0
Monoclonal antibodies in phase II and III trials for moderate to severe atopic dermatitis
Patel H.A., Tran L., Karagenova R., Feldman S.R.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2024 citations by CoLab: 0
ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?
Hansford J.R., Manoharan N., Bouche G., Ramaswamy V., Jabado N., Bouffet E.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2024 citations by CoLab: 0
Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results
Stella L., Hollande C., Merabet Y.B., Fakhouri H., Leclerc V., Ponziani F.R., Bouattour M.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2024 citations by CoLab: 0
A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion
Pan L., Nagib L., Ganguly S., Moorthy A., Tahir H.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2024 citations by CoLab: 1
Current and emerging drug treatment strategies to tackle sickle cell anemia
Persaud Y., Leonard A., Rai P.
Q1
Taylor & Francis
Expert Opinion on Emerging Drugs 2024 citations by CoLab: 0

Top-100

Citing journals

500
1000
1500
2000
2500
3000
3500
4000
Show all (70 more)
500
1000
1500
2000
2500
3000
3500
4000

Citing publishers

2000
4000
6000
8000
10000
12000
14000
16000
18000
Show all (70 more)
2000
4000
6000
8000
10000
12000
14000
16000
18000

Publishing organizations

20
40
60
80
100
120
140
Show all (70 more)
20
40
60
80
100
120
140

Publishing organizations in 5 years

1
2
3
4
5
6
7
Show all (66 more)
1
2
3
4
5
6
7

Publishing countries

200
400
600
800
1000
1200
1400
1600
1800
USA, 1738, 41.88%
United Kingdom, 312, 7.52%
Mexico, 141, 3.4%
India, 136, 3.28%
Canada, 111, 2.67%
Brazil, 96, 2.31%
Republic of Korea, 94, 2.27%
China, 59, 1.42%
Italy, 55, 1.33%
Spain, 54, 1.3%
Australia, 50, 1.2%
Israel, 45, 1.08%
Japan, 44, 1.06%
Denmark, 43, 1.04%
Netherlands, 40, 0.96%
Germany, 39, 0.94%
Peru, 34, 0.82%
France, 32, 0.77%
South Africa, 32, 0.77%
New Zealand, 27, 0.65%
Colombia, 22, 0.53%
Sweden, 22, 0.53%
Benin, 21, 0.51%
Ethiopia, 21, 0.51%
Argentina, 20, 0.48%
Georgia, 20, 0.48%
Turkey, 20, 0.48%
Indonesia, 19, 0.46%
Kenya, 18, 0.43%
Nigeria, 17, 0.41%
Belgium, 16, 0.39%
Costa Rica, 16, 0.39%
Norway, 16, 0.39%
Switzerland, 16, 0.39%
Chile, 15, 0.36%
Ghana, 14, 0.34%
Malaysia, 14, 0.34%
Nepal, 13, 0.31%
Ecuador, 13, 0.31%
Bolivia, 12, 0.29%
Cameroon, 11, 0.27%
Thailand, 10, 0.24%
Greece, 9, 0.22%
Philippines, 9, 0.22%
Venezuela, 8, 0.19%
Tanzania, 8, 0.19%
Pakistan, 7, 0.17%
Puerto Rico, 7, 0.17%
Finland, 7, 0.17%
Portugal, 6, 0.14%
Belize, 6, 0.14%
Zimbabwe, 6, 0.14%
Panama, 6, 0.14%
Singapore, 6, 0.14%
Sri Lanka, 6, 0.14%
Guatemala, 5, 0.12%
Egypt, 5, 0.12%
Laos, 5, 0.12%
Poland, 5, 0.12%
Uganda, 5, 0.12%
Czech Republic, 5, 0.12%
Jamaica, 5, 0.12%
Vietnam, 4, 0.1%
Iraq, 4, 0.1%
Iran, 4, 0.1%
Lebanon, 4, 0.1%
Madagascar, 4, 0.1%
Mali, 4, 0.1%
Saudi Arabia, 4, 0.1%
Sudan, 4, 0.1%
Sierra Leone, 4, 0.1%
Austria, 3, 0.07%
Bangladesh, 3, 0.07%
Honduras, 3, 0.07%
Jordan, 3, 0.07%
Democratic Republic of the Congo, 3, 0.07%
Paraguay, 3, 0.07%
Bahrain, 2, 0.05%
Bulgaria, 2, 0.05%
Burkina Faso, 2, 0.05%
Vanuatu, 2, 0.05%
Côte d'Ivoire, 2, 0.05%
Myanmar, 2, 0.05%
Oman, 2, 0.05%
El Salvador, 2, 0.05%
Serbia, 2, 0.05%
Syria, 2, 0.05%
Slovenia, 2, 0.05%
Trinidad and Tobago, 2, 0.05%
Uruguay, 2, 0.05%
Russia, 1, 0.02%
Estonia, 1, 0.02%
Algeria, 1, 0.02%
Angola, 1, 0.02%
Bhutan, 1, 0.02%
Hungary, 1, 0.02%
Timor-Leste, 1, 0.02%
Gabon, 1, 0.02%
Guinea, 1, 0.02%
Guam, 1, 0.02%
Show all (70 more)
200
400
600
800
1000
1200
1400
1600
1800

Publishing countries in 5 years

5
10
15
20
25
30
35
40
45
50
USA, 47, 33.57%
Brazil, 15, 10.71%
Australia, 8, 5.71%
Mexico, 8, 5.71%
Netherlands, 8, 5.71%
Cameroon, 7, 5%
France, 6, 4.29%
Italy, 6, 4.29%
United Kingdom, 5, 3.57%
Canada, 5, 3.57%
Norway, 5, 3.57%
Ethiopia, 5, 3.57%
Germany, 4, 2.86%
Belgium, 4, 2.86%
Benin, 4, 2.86%
Iraq, 4, 2.86%
Spain, 4, 2.86%
Argentina, 3, 2.14%
Kenya, 3, 2.14%
Colombia, 3, 2.14%
Peru, 3, 2.14%
Czech Republic, 3, 2.14%
China, 2, 1.43%
Vietnam, 2, 1.43%
Georgia, 2, 1.43%
India, 2, 1.43%
Malaysia, 2, 1.43%
Pakistan, 2, 1.43%
Poland, 2, 1.43%
Slovenia, 2, 1.43%
Uruguay, 2, 1.43%
Jamaica, 2, 1.43%
Japan, 2, 1.43%
Russia, 1, 0.71%
Austria, 1, 0.71%
Burkina Faso, 1, 0.71%
Vanuatu, 1, 0.71%
Gabon, 1, 0.71%
Denmark, 1, 0.71%
Egypt, 1, 0.71%
Indonesia, 1, 0.71%
Iran, 1, 0.71%
Yemen, 1, 0.71%
Democratic Republic of the Congo, 1, 0.71%
Côte d'Ivoire, 1, 0.71%
Mali, 1, 0.71%
Nigeria, 1, 0.71%
Saudi Arabia, 1, 0.71%
Sudan, 1, 0.71%
Tanzania, 1, 0.71%
Uganda, 1, 0.71%
Uzbekistan, 1, 0.71%
Philippines, 1, 0.71%
Finland, 1, 0.71%
French Guiana, 1, 0.71%
Chile, 1, 0.71%
Switzerland, 1, 0.71%
Sweden, 1, 0.71%
Sri Lanka, 1, 0.71%
Ecuador, 1, 0.71%
South Africa, 1, 0.71%
Show all (31 more)
5
10
15
20
25
30
35
40
45
50